Characterization and In vivo Evaluation of Polymorphic Valnemulin Hydrogen Fumarate

Area of Science:

• Veterinary Pharmacology
• Drug Development
• Antimicrobial Agents

Background:

• Valnemulin is a pleuromutilin antibiotic used in veterinary medicine.
• Valnemulin hydrochloride has limitations in stability.
• Development of improved formulations is crucial for enhanced therapeutic outcomes.

Purpose of the Study:

• To characterize a novel valnemulin hydrogen fumarate prodrug.
• To compare its stability against valnemulin hydrochloride.
• To evaluate its efficacy in a mouse model of Actinobacillus pleuropneumoniae pneumonia.

Main Methods:

• Physicochemical characterization using microscopy, X-ray diffraction, and spectroscopy.
• Comparative stability studies under light irradiation.
• In vivo efficacy evaluation in a murine pneumonia model.

Main Results:

• Valnemulin hydrogen fumarate exhibited high crystallinity and superior photostability compared to valnemulin hydrochloride.
• The prodrug demonstrated enhanced efficacy in treating Actinobacillus pleuropneumoniae-induced pneumonia in mice.
• In vitro antimicrobial susceptibility testing supported the in vivo findings.

Conclusions:

• Valnemulin hydrogen fumarate possesses favorable stability and efficacy profiles.
• This prodrug represents a promising candidate for veterinary applications.
• Further development could lead to improved treatments for bacterial pneumonia in animals.